For veterans with type 2 diabetes (T2D) receiving basal insulin therapy, the addition of glucagon-like peptide-1 receptor ...

Insulin resistance is one area under investigation. If you have been diagnosed with the condition, here’s how GLP-1s may help ...

Objective Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are increasingly recognised for benefits beyond glycaemic ...

Use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a higher risk for ischemic optic neuropathy ...

Instead, they actively downregulate the core behavioral features of BED, significantly reducing active binge eating episodes, loss-of-control eating, and emotional eating patterns. Drugs commonly used ...

Public interest in obesity medication has risen 25-fold since the launch of GLP-1 receptor agonist drugs, new research presented at the International Congress on Obesity (ICO2026) in Mexico City, ...

GLP-1 receptor agonist weight loss drugs suppress appetite for food but may also reduce mood and desire for sex in some ...

Israel: An analysis of electronic health record data found that adults with type 2 diabetes who used GLP-1 receptor agonists ...

Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is common people with eating disorders, according to a research letter published online June 24 in JAMA ...

Dallas expected to save $12 million on employee healthcare this year, but rising GLP-1 drug use and high-cost claims now have ...

The use of GLP-1 receptor agonists (GLP-1 RAs) was associated with a lower risk for serious infections — particularly respiratory, skin and soft tissue, musculoskeletal, and vascular infections as ...

Poison centers in the US are receiving more GLP-1 RA exposure reports following FDA approval for GLP-1 RA use in weight loss.